Outlook Therapeutics Inc (OTLK)

04:35 AM

Outlook Therapeutics Q3 FY2025 Financial Results and Corporate Update - TradingView

04:35 AM

08:29 AM

Outlook Therapeutics at a Strategic Inflection Point: Regulatory and Commercial Catalysts for Value Creation in the $4B+ Anti-VEGF Market - AInvest

08:29 AM

08:07 AM

Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update - GlobeNewswire

08:07 AM

08:05 AM

Outlook's Eye Drug LYTENAVA Launches in Europe as Critical FDA Decision Approaches - Stock Titan

08:05 AM

Aug 13, 2025

Reversal Traders Monitor Outlook Therapeutics Inc. for EntryChart Breakout Buy Signal Detection Confirmed - 선데이타임즈

Aug 13, 2025

Aug 11, 2025

Outlook Therapeutics, Inc. shares rise 1.94% after-hours due to positive market sentiment. - AInvest

Aug 11, 2025

Aug 11, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Reminds Outlook Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2024OTLK - ACCESS Newswire

Aug 11, 2025

Aug 08, 2025

Outlook Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 04, 2025

Published on: 2025-08-04 15:25:16 - metal.it

Aug 04, 2025

Aug 04, 2025

What are analysts’ price targets for Outlook Therapeutics Inc. in the next 12 monthsUnlock high-yield investment opportunities - Jammu Links News

Aug 04, 2025

Aug 04, 2025

What institutional investors are buying Outlook Therapeutics Inc. stockTriple-digit profit margins - Jammu Links News

Aug 04, 2025

Aug 03, 2025

What are the latest earnings results for Outlook Therapeutics Inc.Game-changing capital returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Outlook Therapeutics Inc. stockFree Capital Allocation Plans - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How volatile is Outlook Therapeutics Inc. stock compared to the marketExceptional portfolio growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Outlook Therapeutics Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Outlook Therapeutics Inc. a good long term investmentUnrivaled growth potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Outlook Therapeutics Inc. company’s balance sheetCapitalize on fast-growing stocks today - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Outlook Therapeutics Inc. stockFree Stock Chart Pattern Guide - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Outlook Therapeutics Inc. stock price move sharplyInvest confidently with expert support - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Outlook Therapeutics Inc. stock higher in 2025Achieve breakthrough performance in the market - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Outlook Therapeutics Inc. stock in 2025Capitalize on emerging market sectors - Jammu Links News

Aug 03, 2025

Aug 02, 2025

How does Outlook Therapeutics Inc. generate profit in a changing economyAchieve triple-digit returns with smart investing - Jammu Links News

Aug 02, 2025

Aug 01, 2025

What is Outlook Therapeutics Inc. company’s growth strategyPre Market Recommendation With Low Risk - Jammu Links News

Aug 01, 2025

Jul 31, 2025

Outlook Therapeutics, Inc. shares rise 1.95% premarket after Eli Lilly's Mounjaro shows heart benefits in a head-to-head study. - AInvest

Jul 31, 2025

Jul 29, 2025

What institutions are buying Outlook Therapeutics Inc. stock nowEntry Points For Growing Stocks Identified by Models - metal.it

Jul 29, 2025

Jul 29, 2025

Ichimoku Cloud Indicates Uncertainty Around Outlook Therapeutics Inc.Real Trader Watchlist of Hot Stocks Released - metal.it

Jul 29, 2025

Jul 29, 2025

What caused OTLK's net profit surge in Q3 2024? - AInvest

Jul 29, 2025

Jul 28, 2025

SHAREHOLDER ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jul 28, 2025

Jul 28, 2025

How many analysts rate Outlook Therapeutics Inc. as a “Buy”Build your wealth with consistent stock growth - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Outlook Therapeutics Inc. stock outlook for YEAR Pattern Recognition Based Market Move Prediction - Newser

Jul 28, 2025

Jul 28, 2025

Why is Outlook Therapeutics Inc. stock attracting strong analyst attentionInvest confidently with professional market insights - Jammu Links News

Jul 28, 2025

Jul 27, 2025

Published on: 2025-07-28 00:00:40 - Jammu Links News

Jul 27, 2025

Jul 27, 2025

Top Risks to Consider Before Buying Outlook Therapeutics Inc. StockSafe High Return Entry Points - Newser

Jul 27, 2025

Jul 27, 2025

Outlook Therapeutics Inc. Stock Support and Resistance Levels You Should KnowBig Return Stock Tips - Newser

Jul 27, 2025

Jul 26, 2025

Why Outlook Therapeutics Inc. stock attracts strong analyst attentionSmall Risk Large Return Trades - Newser

Jul 26, 2025

Jul 25, 2025

Outlook Therapeutics, Inc. shares fall 2.45% after-hours amid mixed market sentiment. - AInvest

Jul 25, 2025

Jul 25, 2025

What analysts say about Outlook Therapeutics Inc. stockPowerful growth strategies - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Outlook Therapeutics to Present at OIS Retina Innovation Summit - AInvest

Jul 25, 2025

Jul 24, 2025

Outlook Therapeutics to Present at the 8th Annual Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase - GlobeNewswire

Jul 24, 2025

Jul 24, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Jul 24, 2025